Impressive Benefits and an Excellent Safety and Tolerability Profiles in Two Severely Affected Patients With Mutations in a Vital Sodium Channel (SCN2A) Treated With Bespoke ASOs Reported in Nature Medicine

Nature Medicine published findings on two SCN2A patients, reporting impressive benefits alongside “excellent” safety and tolerability profiles. The article signals a promising clinical development step, but provides no quantitative effect sizes or timelines, implying limited near-term trading impact.